MARINA DEL REY, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), parent company of The Muscle Company, launches online media blitz to support the re-launch of its core product, MYO-T12®.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10044
MYO-T12®, the world's first clinically validated, is a myostatin-inhibiting dietary supplement. MYO-T12® works by modulating the body's level of myostatin, a genetic protein that restricts muscle growth no matter how hard a person trains and lifts weights. It has been clinically proven to reduce the average serum myostatin levels in the body by up to 46 percent within 12 to 18 hours after one serving.
The multi-spoke creative campaign includes myostatin educational ads; ads featuring MYO-T12® spokesman and NHL Hockey Legend Wayne Gretzky; social networking; Wayne Gretzky autograph memorabilia giveaways; and workout tips by MYO-T12® creator, Dr. Carlon Colker. To kick-off the campaign, MYO-T12® ads are in heavy rotation on ever the popular MensHealth.com and MuscleandFitness.com
"We realize most people are unaware of myostatin and the role it plays in limiting muscle growth and recovery. We feel it is our job to use all forms of media to educate the public and we will be very aggressive with advertising and promotion of the MYO-T12® brand," says JB Bernstein, CEO of Atlas Therapeutics.
About Atlas Therapeutics:
Atlas Therapeutics has acquired MYO-T12®, the world's only clinically validated Myostatin modulator. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. MYO-T12® is manufactured to optimize biological activity and has the potential to redefine existing standards of physical enhancement. Atlas is focused on preserving and growing the existing brand identity of MYO-T12® by refining its technical profile, and designing and implementing a marketing and sales strategy to increase penetration of the product into the existing health and fitness community.
The Atlas Therapeutics Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10042
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
